{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-21-020237","form_type":"8-K","ticker":"XFOR","cik":"0001501697","company_name":"X4 Pharmaceuticals, Inc","filed_at":"2021-10-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.766493+00:00","generated_at":"2026-06-28T19:57:55.748389+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"X4 Pharmaceuticals appoints Francoise de Craecker to Board and Compensation Committee","bullets":["Francoise de Craecker appointed as Class III director effective Oct 14, 2021, term through 2023 annual meeting.","She replaces Alison Lawton on the Compensation Committee; Lawton remains on the Board.","Received initial option to purchase 12,250 shares vesting over three years, with full acceleration on change of control.","Compensation follows standard non-employee director policy as described in the 2021 proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-21-020237","json":"https://secwatch.observer/filing/0001628280-21-020237.json","markdown":"https://secwatch.observer/filing/0001628280-21-020237.md","text":"https://secwatch.observer/filing/0001628280-21-020237.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501697/000162828021020237/0001628280-21-020237-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501697/000162828021020237/xfor-20211014.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T19:57:55.748389+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c14f2f46cf","claim":"Francoise de Craecker was appointed as Director at X4 Pharmaceuticals, Inc.","evidence_excerpt":"On October 14, 2021, the Board of Directors (the “Board”) of X4 Pharmaceuticals, Inc. (the “Company”) appointed Francoise de Craecker as a member of the Company’s Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828021020237/0001628280-21-020237-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}